In response to rising consumer complaints, India's drug regulator is set to implement new labelling norms for medicines that prioritise readability and help make informed choices ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The US Food and Drug Administration (FDA) has issued an urgent warning about tianeptine – a substance marketed as a dietary ...

Rapid diagnostics continue transforming healthcare delivery worldwide, fueled by aging populations, decentralized care models, technological converge ...